Pathway

Acquired by Bayer's Medrad unit

GizaVC invests in the vision of most innovative entrepreneurs.

About

Medical devices for the treatment of peripheral arterial disease.

pathway c

 

Bayer's Medrad unit acquired Pathway for $125 million in 2011

Founders

Thomas J. Clement, David C. Auth

 

Fields of invesment: icon life Healthcare

Contact info:icon internet Website